Metastatic Renal Medullary Carcinoma Treated With Immune Checkpoint Inhibitor: Case Report and Literature Review

Clin Genitourin Cancer. 2018 Dec;16(6):e1087-e1090. doi: 10.1016/j.clgc.2018.07.011. Epub 2018 Jul 21.
No abstract available

Keywords: Immunotherapy; Nivolumab; PD-L1; Renal-cell carcinoma; Treatment.

Publication types

  • Case Reports
  • Review

MeSH terms

  • Adult
  • Antineoplastic Agents, Immunological / therapeutic use*
  • Carcinoma, Medullary / immunology
  • Carcinoma, Medullary / pathology
  • Carcinoma, Medullary / therapy*
  • Carcinoma, Renal Cell / immunology
  • Carcinoma, Renal Cell / pathology
  • Carcinoma, Renal Cell / therapy*
  • Chemoradiotherapy, Adjuvant / methods
  • Female
  • Humans
  • Kidney Neoplasms / immunology
  • Kidney Neoplasms / pathology
  • Kidney Neoplasms / therapy*
  • Lymph Node Excision
  • Lymphatic Metastasis / pathology
  • Nephrectomy
  • Nivolumab / therapeutic use*
  • Programmed Cell Death 1 Receptor / antagonists & inhibitors
  • Treatment Outcome

Substances

  • Antineoplastic Agents, Immunological
  • PDCD1 protein, human
  • Programmed Cell Death 1 Receptor
  • Nivolumab